Windtree Therapeutics Inc (NASDAQ: WINT) Continues To Thrive In 2025, As Its Stock Is Down -93.47% Year-To-Date
During the last session, Windtree Therapeutics Inc (NASDAQ:WINT)’s traded shares were 63861.0, with the beta value of the company hitting 0.79. At the end of